OneVentures Welcome Image

OneVentures is a venture capital firm headquartered in Sydney, Australia that provides human and investment capital into high growth companies with a particular focus on transformative technologies.

The firm is particularly focused on opportunities originating in Australia which are poised to expand into the established and emerging global markets.

All of our Partners have founded, built and exited high-growth businesses.

Our goal is to be the leading Australian early stage venture capital company.

Proudly supporting

Heads Over Heels
Investor Portal Log In

Connect With Us

About OneVentures

OneVentures invests in technology companies that serve or disrupt large high growth global markets. The firm has $140M in funds under management recently launching its new Innovation and Growth Fund II which is focused on growth and expansion stage technology companies.

OneVentures is managed by a team of Partners with a skill-set and track record ideally suited to collaboration with entrepreneurial management teams to foster growth and create value: a unique blend of highly successful entrepreneurs, technology business founders and corporate executives with a strong scientific pedigree, extensive off-shore experience and networks.

The OneVentures team is committed to deliver investor returns by applying this expertise to select portfolio companies with significant potential then accelerating their performance.


OneVentures Management Pty Ltd is a designate under OneVentures Nominees Pty Ltd's AFSL (Licence No: 462825) issued by the Australian Securities and Investments Commissions, authorising the Manager to provide such financial services as the Manager provides during the course of its duties as manager of the Fund.

The OneVentures Team

All Partners have many years of C-level, board and investment experience. Coupled with this is a track record of identifying investment opportunities in global markets with strong international business backgrounds and networks. The OneVentures Investment team has 7 technology related higher degrees.

Dr Michelle Deaker

Dr Michelle Deaker
Managing Director and CEO

Dr Paul Kelly

Dr Paul Kelly
Partner and Managing Director

Anne-Marie Birkill

Anne-Marie Birkill
General Partner and Executive Director

Melissa Widner

Melissa Widner
Venture Partner

Daniel Gammell

Daniel Gammell
Investment Manager

Dr Amir Zalcenstein

Dr Amir Zalcenstein
Investment Manager, Healthcare

Helen Liu

Helen Liu
Chief Financial Officer

Jelly Jakob

Jelly Jakob


Innovation Fund (Fund I)

The OneVentures Innovation Fund is a $40M venture capital fund formed as an early stage venture capital Limited Partnership. This Fund was launched in 2010 with the Commonwealth Government committing $20M from its IIF programme and this funding matched by high net-worth wholesale investors.

Innovation and Growth Fund (Fund II)

The OneVentures Innovation and Growth Fund was launched in March 2014 with a target of $100M and has reached first close of $60M as of October 2014. Fund II is an early stage venture capital limited partnership backed entirely by Australian high net-worth wholesale investors.

Focusing on later stage (Series B and beyond) investments while still maintaining some investment activity in the earlier stage investments, Fund II is now screening investment opportunities where the experience of the OneVentures management team can be leveraged to accelerate value creation and company success.

We are currently looking for truly transformative companies to join our portfolio of innovative companies, if you think your company has what it takes, read our Application for Funding page and submit your application now.

Investment Portfolio

OneVentures Innovation Fund (Fund I)

Other Investments

Latest News

  • Emerging systems to integrate Charm into EHS

    by OneVentures Administrator | Jul 30, 2015
    Date: 30 July 2015
    Author: Kate McDonald
    Source: Pulse+IT Magazine

    Sydney-based clinical information system vendor Emerging Systems has signed a memorandum of understanding to form a strategic alliance with Brisbane-based oncology software specialist Charm Health which will see Charm integrated into Emerging Systems' EHS acute care system.

    Emerging Systems was 
    bought by Telstra Health in December last year and is best known for its long-term client St Vincent's Hospital in Sydney, where EHS is known as De Lacy.

    St Vincent's was the first hospital and EHS the first clinical information system to connect to the PCEHR.

    According to Telstra Health, the integration of the Charm system into the Emerging platform will enable hospitals to provide a more comprehensive medical record for cancer patients, including populating e-discharge summaries for GPs and uploading into the PCEHR.

    Emerging Systems' managing director Russel Duncan said the formation of this partnership would help build on the ambition for a connected healthcare system to deliver better results for patients.

    “Telstra Health has built its strategy on connecting and integrating the various components of the health system,” Mr Duncan said in a statement.

    “This partnership is another example of bringing that strategy to life, making it easier for hospitals by removing the worry about needing to tailor solutions to ensure interoperability, while also allowing better information sharing across the continuum of care, including hospital, primary and ambulatory care settings.”

    Charm Health’s flagship product has multi-site functionality that can manage the clinical and administrative coordination of a patient’s cancer care. The specialist software has about 45 deployments to Australian public and private cancer care providers.

    Charm recently signed a master licensing agreement with private hospital operator Healthscope to allow any Healthscope hospital offering oncology services to licence the product and take advantage of a new rapid deployment methodology it has developed.

    Charm Health CEO Gary Lakin said the arrangement with Emerging Systems would make Australian-based health IT solutions more appealing in a market that still has a tendency to be drawn to international solutions requiring significant changes to fit Australian conditions.

    “We’re a proud Australian company with an intimate understanding of Australian health requirements,” Mr Lakin said. “Working with Telstra Health provides a chance to build on this and offer a better solution for Australian cancer patients and hospitals.”

    In addition to St Vincent's Hospital in Sydney, EHS is being rolled out to the other St Vincent's Health Australia public and private hospitals and is also being implemented by St John of God Health Care.

    It is set to go live when the new St John of God Midland Public opens in Perth later this year. The hospital is replacing the Swan District Hospital and is due to open in November.

Full story

Contact Us

For Entrepreneurs

We are now screening companies for OneVentures Fund II which is a Series A and beyond growth fund focusing on the technology sector. To qualify for funding, your company should meet the following criteria: 

  • Australian domiciled company
  • We invest in technology companies from many sectors, but we are particularly interested in companies from the following sectors: healthcare, education, mobile, media, cloud computing and data, security and privacy, machine learning, software, sensors and robotics or food security
  • If a life sciences company, your product should have a strong proof of concept and be at a minimum, in a late stage clinical trial and/or well progressed through the regulatory process
  • If from another sector, your company should be generating sustainable revenue and have a strong market validation
  • Approaching profitability with capital required to fuel growth and global expansion

If you meet the above criteria, send us a brief document (a 2-page executive summary or introductory PowerPoint is sufficient, please do not send larger documents or full information memorandums at this stage) covering at a minimum the following points to

  • Summarize in 2 sentences what your company does (this is important)
  • Identify the market, value proposition and your competitive advantage
  • Tell us about your progress to date
  • State your revenue for the last financial year and projected revenue for current financial year
  • Indicate capital required and how it will be used
  • Include 3 point bios of each executive and contact details

We will review your proposal and endeavour to revert to you within 2 weeks. 


For Investors And General Enquiries:

General enquiries:
Investor enquiries:
Telephone: +61 2 8205 7379


OneVentures Pty Ltd
Suite 304, Level 3
1 Alfred Street
Sydney NSW 2000


c/- Interfinancial
Level 3, 145 Eagle Street
Brisbane QLD 4000

For media enquiries

For an interview with a OneVentures' spokesperson, please contact Honner Media at +61 2 8248 3744.